Cabozantinib S-Malate vs Rituximab

## Cabozantinib S-Malate vs Rituximab: Overview

This comparison examines the pharmacological differences between **Cabozantinib S-Malate** and **Rituximab**.

## Mechanism of Action

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Cabozantinib S-Malate — N/A; Rituximab — 22 days.

## Chemical Properties

**Type**: Cabozantinib S-Malate — Small molecule; Rituximab — Antibody.